Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I've read a few comments of people who are disapppointed that STC is giving away free kits. At this stage i am not concerned. STC is new to the market and it needs to spread awareness. Giving away free kits is a good way of getting it into peoples homes. If the users of the freebies have a good experience then they will tell others.
But that is a short term commercial view. Longer term every kit given away for free results in data coming back into DVRG, data that is worth money. In time this data will be worth a heck of a lot to the right parties.
If a new brewer gives away promotional pints to raise awareness is hopes that the customer will tell others and become a long term customer themselves. STC are doing something similar, however, unlike with a pint, the consumption of a STC kit gives DVRG data it can sell.
DVRG also has other revenue generating divisions (labskin, microtox etc). It can afford to support STC to an extent, certainly if it lays the foundations of the launch pad for STC to take off
GB has just posted a tweet which seems to indicate that the PD will detect the omircon variant. Great news if so
Thanks paulcon,
I believe that the spike protein of the covid particles is detected by the aptamers/affirmers. The variants are all still cut from the same cloth, so to speak, so hopefully the PD (and BT) can still detect the new strains.
A brand new virus would be a different conversation. DVRG (and partners) would need to get to work pretty damn quickly to tweak the technology to identify a new virus. If they couldnt then the surveilance system would fall down.
Obviously microtox can still detect a variety of existing viruses and bacteria, as well as other contaminents in waste water. So the microtox brand certainly doesnt live or die on the success of detecting future pandemics. All imo
Morning glebe.
When (if?) the deal with CR is signed off it will be a massive day for DVRG holders in terms of progress. It probably wont result in the SP bagging because the news needs to be understood and digested outside of the "parish". But, it will give all DVRG holders assurances that the PD is going to be mass manufactured and we will likely see contracts announced in the months to follow. These contracts will be the catalyst to SP gains. For example, announcing a three year contract to kit out all water treatment plants in a given country will be worth many many millions to DVRG. Such a contract will lead to major SP gains imo
The new variant will certainly act as a wake up call for those who think covid is a distant memory. However, the CR deal isnt signed (yet) and once signed we are probably a couple of months away from manufacturing in China, which means we are probably another month away from assembly in Cork. The earliest i see PD being available on any sort of mass (200 a month) is April. By this time we may well be back in head burying mode with regards to covid as omicron is likely to have done it's thing by then and we will be heading towards the summer months
At 200 units a month, PD offers the dream of pandemic surveilance to a sole country in about 3 years time. The demand could be so high for this that 200 a month may not even make a scratch
Signed up contracts will need to be met. Hopefully DVRG and CR can ramp up production. For me, 200 a month doesnt seem like much. Especially if schools/office buildings are expected to be using these in the years to come. That could be 10's of thousands of PD units in the UK alone. Great for business, but such demand can't be met with "only" 200 a month
I don't doubt CR's abilities to manufacture the required parts on the scale required, it's the DVRG in-house assembly in Cork that i can see having issues assembling to the scale required. All imo, of course. And baby steps for sure. 200 a month will be just fine for our investments in DVRG. If we are ever having the conversations about DVRG struggling to meet the demand then DVRG is a billion pound+ mcap company and we are all stinking rich!
POLB will take 12-18 months to monetise an asset, per the various POLB presentations. And that is IF the "shot on goal" goes into the back of the net.
Based on this, POLB wont have monetised any of the assets by the time the lock in ends. The only way, imo, that will prevent ORPH holders heading for the exit is that they make positive progress over the next 4 months and start buying up intriguing medicines/vaccines (the "shots on goal"). If not, and the SP remains beneath IPO, i see a lot of ORPH holders seeing POLB as a bird in hand being worth more than two in the bush.
Some ORPH holders will have tens of thousands of pounds in POLB, an investment they never "chose". I think that said investors will have no issue deciding to cash in.
So, from a POLB perspective, it's over to CF and JS to convince perhaps 50% of the shareholders not to cash their chips.
His suggestion of a 1 billion dollar market cap within a year is a little wide of the mark as things stand, 6 months in. This may have been a tongue in cheek comment by CF, but i doubt he expects the reality to be less than IPO at the end of the lock in. A NASDAQ application (suggested by CF to occur within a year) would encourage a few to stick around, i am sure
As i understand it, the business targetting £50m revenue and profitability will still exist after DIM, Prep and Imutex are spun off.
At present the three are effectively dormant assets within ORPH. Will the SP take a hit when the assets are spun off? Probably yes, as it did when POLB was spun off. But the "shell" that will be ORPH will still be generating £50m plus a year, and will be profitable. As elrico has said, ORPH will then be a pure CRO. What becomes of said CRO? Who knows. Some have suggested a sale, others a NASDAQ listing. I think we will have the answer within the next year or two
The SP was at about 43p last Thursday on the news of the merchants. It was the boots et al u-turn (if JR is to be believed) that resulted in the SP starting to turn.
If JR was able to get these guys interested he needs to follow it up and sign up more household names, affiliate links or not
That will move the SP. They need to target a big name to follow up THG. If they got one of the takeaway companies on board, for example, the SP would rocket like it did when the market thought boots/homebase/ocado were
The share price movement here is very painful, but i feel that the MCAP of £25 million is cheap for what MODE have:
- FCA regulated crypto app
- cheapest BTC fees (can't be beaten until 1 January)
- BTC cashback
- merchant offering with The Hut Group and various other businesses (and counting) and UK charity
- cheaper merchant fees than the big boys VISA and mastercard. Amazon are looking to drop VISA credit due to high fees, for example. Per JR we have made contact with amazon...
- looking to leverage open banking. Seamless QR code payment system in operation for the sites that have MODE pay enabled
- payroll deductions into BTC via payescape
- teamed up with online influencers (pomp, brunel)
- £800k revenue during the 6 months to 30 June prior to any promotion, merchant launch or payroll tie in
- strong board and alipay links
- OTC listing, which hasnt done much for us yet. But as the MODE name spreads (pomp will help) i see US investors taking a position
I am invested in companies that are pre-revenue and have a larger MCAP than MODE, much larger
I think the following is to blame for the current SP action:
- new covid variant scaring the markets
- BTC decline
- bad PR re boots, homebase and ocado debacle
The market makers love marking down MODE and they are using the above reasons as justification.
The reality is MODE is growing as a business and i am looking forward to its future. £25m for all of the above? If it IPO'd today it would be worth a lot more, especially when compared to what other similar platforms are valued at (billions)
The SP stings but i wont be selling. Probably a bottom drawer investment for now whilst we wait on more news and progress. Others will disagree with my sentiment, and they will point to the SP as justification of theirs, but strip back the SP noise and the business offering is growing, not declining
Back in March we were in the low 80's with a lot less of a business than we have today. It tested 83/84p a number of times. Granted that was probably based on the ARB buzz, with a load of their PIs jumping out at the ARB highs of £3.20
MODE definitely dropped the ball last week, but JR is adamant there was an affiliate agreement with these companies.
The only way to get PIs back on side is to follow up last weeks news with even more. Get some big companies on side and follow up the botched sign up of boots, homebase and ocado with some more household names. Hopefully the imminent broker note reveals some interesting information and helps improve the mood in the MODE PI camp
GLA LTH
That information may well be disclosed under the integumen (SKIN) RNS's. I can only go as far back as the inception of DVRG on LSE
DRS1, Gerard could have asked for the 1 millon shares and sold them over a period of a few weeks and received £250k at the present SP.
His conversion price was 8p, a lot lower than today's price. If he feels the SP is going to drop off he would still be a lot better off financially taking the shares and flipping them on the open market
If his conversion price was 30p you may have a point. It would suggest he didnt think he would make profit in the short term and suggest he didnt believe in the SP trajectory. That isnt what is happening here. 8p a share would be profitable even if the SP dropped 65%
If the TP price target of close to £1 can be believed then Gerard and Camillus have turned down over £1m in perhaps a year or two for a hundred or so thousand pounds today. And in the interest of the company as a whole. That really is impressive and an admirable decision.
It is clear Gerard doesnt want to dilute the share pool any more than is necessary and through his actions in the RNS this morning it is clear he is looking out for us PIs and the effect it would have on our investments.
A cynic could say it's because he expects the share price to crash beneath 8p and thus cash now is more beneficial, but that is ridiculous.
As a long term holder i appreciate this latest development
Agreed stoater. I couldnt see that GB and camillus were the recipients. My phone compresses the LSE tables so i could only really make out the values. GB and camillus are the recipients of these funds and they have opted for cash over an effective 1.1% dilution
My first post was on an assumption it applied to former directors. Apologies for jumping the gun
But in fairness to GB, he clearly expects the former directors to dump their 8p shares more or less immediately and thus a real drag on the SP. In this respect, it certainly protects the SP. A news rich period is upon us. We dont want any gains to be sold into by former directors who picked up shares for 8p
I wonder how many further obligations we have to former employees of the company? Hopefully this settles the skeletons in the proverbial closet!
It will result in paying out around £500k. Not sure how much cash we have at this moment, but £500k is a serious chunk of change. If this cash outlay brings forward any future raise by 6 months or so then we will suffer dilution sooner as a result. However, hopefully the next raise, if it's required, will be at 50p+. It certainly wouldnt be at 8p!
"Within 15 minutes" is quite a long time. I appreciate BT is going for the diagnosis of numerous ailments, but it can detect covid more or less instantly, albeit a reader is required to get the result
The comments seem very positive, i look forward to listening to the recording. Well done to all those who sat in on the live event and pushed the DVRG cause. GB and the company would be under NDA's, but industry commentators who would know these things arent necessarily bound by the same rules (at least, the DVRG admission would suggest not)
Simply put, no updated guidance between now and 31 December 2021 means annual revenues of £9m - £11m. I think there are some who would be content with that and others that wont.
We beat the £4m 2020 guidance by about 10%, hopefully we can do the same in 2021, or better yet, smash it and result in an updated guidance RNS being issued. At this point in the year i can only really see STC/labskin sales making much of a bump to the 11 months to date (whatever that is). Any MW contracts entered into in recent weeks (and potentially over the next 5 weeks) will be for work to be delivered in 2022, and therefore likely to result in 2022 revenue
So, a barnstorming x,y,z millions contract announced in December will do little for the 2021 revenue
Great work T.rat, as always, it's very much appreciated. Our customers have deep pockets :-)
Thanks Gerard, that is very informative. It sounds like the range of recommended products will only grow, which is very reassuring. In a year's time a given test could recommend many more products than would be recommended now as Labskin continues to test and approve more and more products.
I feel STC can be a very successful revenue stream. I am looking forward to the revenue forecast for 2022. If we can get the CR deal under our belts this this year/very early next, and with STC going live in further countries, i can see 2022 being a transformational year for DVRG as the solid foundations that have been laid since 2018 start to bear fruit